Next Article in Journal
Effects of Antioxidants in Reducing Accumulation of Fat in Hepatocyte
Next Article in Special Issue
Widespread Expression of Hedgehog Pathway Components in a Large Panel of Human Tumor Cells and Inhibition of Tumor Growth by GANT61: Implications for Cancer Therapy
Previous Article in Journal
Pulmonary Vascular Platform Models the Effects of Flow and Pressure on Endothelial Dysfunction in BMPR2 Associated Pulmonary Arterial Hypertension
Previous Article in Special Issue
Emerging Roles of Sonic Hedgehog in Adult Neurological Diseases: Neurogenesis and Beyond
Open AccessReview

Role of GLI Transcription Factors in Pathogenesis and Their Potential as New Therapeutic Targets

Laboratory for Hereditary Cancer, Division of Molecular Medicine, Ruđer Bošković Institute, Bijenička cesta 54, 10000 Zagreb, Croatia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(9), 2562; https://doi.org/10.3390/ijms19092562
Received: 23 July 2018 / Revised: 17 August 2018 / Accepted: 25 August 2018 / Published: 29 August 2018
(This article belongs to the Special Issue Hedgehog Signaling)
GLI transcription factors have important roles in intracellular signaling cascade, acting as the main mediators of the HH-GLI signaling pathway. This is one of the major developmental pathways, regulated both canonically and non-canonically. Deregulation of the pathway during development leads to a number of developmental malformations, depending on the deregulated pathway component. The HH-GLI pathway is mostly inactive in the adult organism but retains its function in stem cells. Aberrant activation in adult cells leads to carcinogenesis through overactivation of several tightly regulated cellular processes such as proliferation, angiogenesis, EMT. Targeting GLI transcription factors has recently become a major focus of potential therapeutic protocols. View Full-Text
Keywords: HH-GLI signaling pathway; GLI transcription factors; signal transduction; malformations; cancer; therapy HH-GLI signaling pathway; GLI transcription factors; signal transduction; malformations; cancer; therapy
Show Figures

Graphical abstract

MDPI and ACS Style

Sabol, M.; Trnski, D.; Musani, V.; Ozretić, P.; Levanat, S. Role of GLI Transcription Factors in Pathogenesis and Their Potential as New Therapeutic Targets. Int. J. Mol. Sci. 2018, 19, 2562.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop